Bioalternatives has initiated a tissue engineering R&D program in order to develop a skin equivalent model incorporating melanoma cells.

After different tests on monolayer cultures, two cancer lines issued from melanomas (among those available in Bioalternatives) were selected to be integrated as standard in a normal skin equivalent model (3D culture):

  • A-375 line (ATCC® CRL1619): cells issued from metastatic melanoma
  • WM266-4 line (ATCC® CRL1676): cells issued from metastatic melanoma

3D cell culture has allowed us to obtain 2 models corresponding to different stages of development and severity, in which:

  • The A-375 line presents an aggressive profile and results in very important epidermis destruction and equivalent dermis invasion over culture time
  • The WM266-4 line develops a less aggressive response: after 10 to 12 days of culture, the epidermis part of reconstructed skin shows fairly good histology and cancer cells form clusters that are easily identifiable in histology. The cluster size increases over culture time.

Read more…

Recent Posts

VivaTech 2025: Givaudan spotlights digital story-smelling and tech-driven fragrances via Premium Beauty News

Beatrice Wihlander 11 June 2025 Givaudan is showcasing its fragrance technologies, which are underscored by…

ISO 23675: A new validated standard for SPF determination by Zurko Research

After over 10 years of testing sunscreen products, at Zurko Research we are proud to…

This sticker reads emotions (even the ones you try to hide) via Popular Science

Mack Degueurin 22 April 2025 The wearable device analyzes the tiny changes in physical responses…